199 related articles for article (PubMed ID: 2555703)
1. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.
Cleveland JL; Dean M; Rosenberg N; Wang JY; Rapp UR
Mol Cell Biol; 1989 Dec; 9(12):5685-95. PubMed ID: 2555703
[TBL] [Abstract][Full Text] [Related]
2. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Engelman A; Rosenberg N
Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
[TBL] [Abstract][Full Text] [Related]
3. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line.
Mathey-Prevot B; Nabel G; Palacios R; Baltimore D
Mol Cell Biol; 1986 Nov; 6(11):4133-5. PubMed ID: 3025637
[TBL] [Abstract][Full Text] [Related]
4. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.
Kipreos ET; Wang JY
Oncogene Res; 1988 Feb; 2(3):277-84. PubMed ID: 3259302
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of IL-3 dependence of myeloid FDC-P1 cells by tyrosine kinase oncogenes is associated with induction of c-myc.
Cleveland JL; Dean M; Wang JY; Hedge AM; Ihle JN; Rapp UR
Curr Top Microbiol Immunol; 1988; 141():300-9. PubMed ID: 3265092
[No Abstract] [Full Text] [Related]
6. Interleukin-3 dependent mitogenesis in murine cells involves a predominant non-protein kinase C (pKC) dependent pathway for c-myc transcription. Role of a myc expression vector in rescuing pKC dependent mitogenesis.
Nahreini TS; Litz-Jackson S; Burgess GS; Helvering LM; Manolagas SC; Boswell HS
Leukemia; 1991 Dec; 5(12):1099-109. PubMed ID: 1774959
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells: c-jun/AP-1 expression versus c-myc transcription.
Litz-Jackson S; Miller AH; Burgess GS; Boswell HS
Blood; 1992 May; 79(9):2404-14. PubMed ID: 1571552
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL confers growth factor independence upon a murine myeloid cell line.
Mandanas RA; Boswell HS; Lu L; Leibowitz D
Leukemia; 1992 Aug; 6(8):796-800. PubMed ID: 1379313
[TBL] [Abstract][Full Text] [Related]
9. Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl.
Laneuville P; Sun G; Timm M; Vekemans M
Blood; 1992 Oct; 80(7):1788-97. PubMed ID: 1327283
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.
Weissinger EM; Eissner G; Grammer C; Fackler S; Haefner B; Yoon LS; Lu KS; Bazarov A; Sedivy JM; Mischak H; Kolch W
Mol Cell Biol; 1997 Jun; 17(6):3229-41. PubMed ID: 9154822
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow-derived cell lines.
Ahmed N; Berridge MV
Leuk Res; 1997 Jul; 21(7):609-18. PubMed ID: 9301681
[TBL] [Abstract][Full Text] [Related]
12. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
Keller JR; Ruscetti SK; Ruscetti FW
Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
[TBL] [Abstract][Full Text] [Related]
13. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
Sánchez-García I; Grütz G
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5287-91. PubMed ID: 7777499
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
15. Role of myc in the abrogation of IL3 dependence of myeloid FDC-P1 cells.
Dean M; Cleveland JL; Rapp UR; Ihle JN
Oncogene Res; 1987 Aug; 1(3):279-96. PubMed ID: 2453016
[TBL] [Abstract][Full Text] [Related]
16. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
[TBL] [Abstract][Full Text] [Related]
17. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line.
Carlesso N; Griffin JD; Druker BJ
Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574
[TBL] [Abstract][Full Text] [Related]
18. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
Shore SK; Bogart SL; Reddy EP
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
[TBL] [Abstract][Full Text] [Related]
19. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS
Blood; 1993 Sep; 82(6):1838-47. PubMed ID: 7691239
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Heckford SE; Gelmann EP; Matis LA
Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
